STAT+: Moderna to pay Roivant up to $2.25 billion to settle patent lawsuit behind mRNA vaccines
STAT [Unofficial]
March 3, 2026
A settlement provides a massive windfall for Arbutus and Roivant and avoids a worst-case scenario for Moderna.
Discussion in the ATmosphere